Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  Liberty Health Sciences Inc.    LHS   CA5305621073

LIBERTY HEALTH SCIENCES INC.

(LHS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
Strengths
  • The share is getting closer to its long-term support in weekly data, at CAD 0.38, which offers good timing for buyers.
  • Graphically speaking, the timing seems perfect for purchasing the stock close to the CAD 0.43 support.
Weaknesses

No significant weakness

Ratings chart
Sector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
LIBERTY HEALTH SCIENCES INC..-24.59%122
-
JOHNSON & JOHNSON-1.37%378 744
ROCHE HOLDING AG-4.28%281 946
PFIZER INC.-6.59%203 437
MERCK & CO., INC.-11.89%202 757
NOVARTIS AG-12.66%200 273
ABBVIE INC.17.42%183 539
NOVO NORDISK A/S6.76%152 574
BRISTOL-MYERS SQUIBB COMPAN..-1.51%142 861
ASTRAZENECA PLC5.17%140 189
ELI LILLY AND COMPANY10.25%131 364
AMGEN INC.-8.55%128 345
SANOFI-6.04%125 712
GLAXOSMITHKLINE PLC-22.43%91 727
CHUGAI PHARMACEUTICAL CO., ..35.77%71 666
JIANGSU HENGRUI MEDICINE CO..19.52%69 882
More Results
Financials
Sales 2020 50,1 M 38,5 M 38,5 M
Net income 2020 22,3 M 17,1 M 17,1 M
Net Debt 2020 2,19 M 1,68 M 1,68 M
P/E ratio 2020 9,00x
Yield 2020 -
Capitalization 159 M 122 M 122 M
EV / Sales 2019 36,8x
EV / Sales 2020 3,77x
Nbr of Employees 294
Free-Float 99,0%
Upcoming event on LIBERTY HEALTH SCIENCES INC.
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating -
Investor Rating -
Growth (Revenue) -
Valuation -
Finances -
Profitability -
Earnings quality -
Business Predictability -
P/E ratio -
Potential -
Yield -
Consensus -
7 days EPS revision -
4 months EPS revision -
1 year EPS revision -
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes